Table 2.
Clinical parameters | Total | Sema3a expression | P-value | ||
---|---|---|---|---|---|
|
|||||
Low (-~+) | Middle (++) | High (+++) | |||
|
|||||
(n = 70) | (n = 31) | (n = 27) | |||
Gender | 0.976 | ||||
Male | 88 | 48 | 21 | 19 | |
Female | 40 | 22 | 10 | 8 | |
Age (years) | 0.990 | ||||
< 50 | 20 | 11 | 5 | 4 | |
≥ 50 | 108 | 59 | 26 | 23 | |
Tumor size (cm) | 0.394 | ||||
< 4 | 53 | 26 | 16 | 11 | |
≥ 4 | 75 | 44 | 15 | 16 | |
Location | 0.924 | ||||
Cardia | 37 | 21 | 9 | 7 | |
Body/Antrum | 91 | 49 | 22 | 20 | |
Growth pattern | 0.403 | ||||
Expanding type | 65 | 33 | 19 | 13 | |
Infiltration type | 63 | 37 | 12 | 14 | |
TNM stage | 0.003* | ||||
Stage I/II | 85 | 38 | 23 | 24 | |
Stage III/IV | 43 | 32 | 8 | 3 | |
Differentiation | 0.015* | ||||
Well/moderate | 54 | 25 | 11 | 18 | |
Poor | 74 | 45 | 20 | 9 | |
Depth of invasion | < 0.001* | ||||
T1/T2 | 80 | 32 | 23 | 25 | |
T3/T4 | 48 | 38 | 8 | 2 | |
H.pylori infection | 0.142 | ||||
Negative | 46 | 23 | 9 | 14 | |
Positive | 82 | 47 | 22 | 13 | |
Lymphnode metastasis | 0.029* | ||||
Negative | 61 | 29 | 13 | 19 | |
Positive | 67 | 41 | 18 | 8 | |
Vascular invasion | 0.001* | ||||
Negative | 58 | 27 | 10 | 21 | |
Positive | 70 | 43 | 21 | 6 | |
Distant metastasis | 0.002* | ||||
M0 | 120 | 69 | 25 | 26 | |
M1 | 8 | 1 | 6 | 1 |
aStatistical analyses were performed by the Pearson χ 2 test.
P-value < 0.05 was considered statistically significant.